TherapeuticsMD Inc.

TXMD | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.10

-$0.09 (-4.11%)

At close: Sep 21, 2026, 4:00 PM ET

$2.10

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-4.11%

(1D)

Rating

Updated: Aug 19, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $24.31M

1D Range

2.05 2.19

52W Range

0.99 2.95

Valuation (TTM)

PE -94.59

PB 0.90

EV/EBITDA -6.80

Valuation (NTM)

Forward PE 11.06

Forward PEG -9.49

Price Target N/A

Cash Flow

FCF Yield 12.9%

SBC Adj. FCF Yield 12.9%

SBC Impact -0.2%

Margins

Gross Margin 89.9%

Operating Margin -118.2%

FCF Margin 95.9%

Growth (CAGR)

Revenue 3Y | 5Y -47.8% | -47.9%

Dil EPS 3Y | 5Y 129.4% | 70.4%

FCF 3Y | 5Y -54.0% | -46.7%

Returns

ROA -0.6%

ROE -0.8%

ROIC -11.5%

Financial Health

Net Cash

$9.19M

Current Ratio 3.22

Interest Coverage -963.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; BIJUVA, a bio-identical...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 1

IPO Date May 8, 2007

Website www.therapeuticsmd.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 17, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞